PoliCheck Network
← Back to bills
H.R. 8260119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cardiovascular Disease Early Detection and Prevention Act of 2026

Introduced: Apr 14, 2026
Latest action: Apr 14, 2026

Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

1
Primary Sponsors
0
Cosponsors
2
Recorded Actions
0
Linked Votes

Plain-English AI Summary

What this bill means

Generated from the official bill text to make the legislation easier to understand.

Not Generated

A plain-English AI summary has not been generated for this bill yet.

Official Summary

Official legislative summary associated with this bill.

No official summary is currently available.

Primary Sponsors

Members listed as primary sponsors of this legislation.

Cosponsors

Members who joined this legislation as cosponsors.

No cosponsors found.

Recorded Actions

Official legislative actions recorded for this measure.

H11100Apr 14, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official source ↗
Intro-HApr 14, 2026

Introduced in House

Official source ↗

Linked Votes

Roll-call votes associated with this legislation.

No roll-call votes are currently linked to this bill.

Lobbying Activity

Federal lobbying disclosures that explicitly identify H.R. 8260. These records show reported lobbying involving the legislation; they do not establish that every member of Congress, sponsor, or voter was personally contacted.

ALTRIA CLIENT SERVICES LLC

Registrant: ALTRIA CLIENT SERVICES LLC

2nd Quarter (Apr 1 - June 30)
Jul 20, 2026

Reported lobbying issue

Budget/Appropriations: HR 8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; Section 766, related to provisions regarding the regulation of tobacco products and provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 9310: Department of Homeland Security Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8260/S 2587: Departments of Labor, Health and Human Services and Education and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8845/S 2354: Commerce Justice Science and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 8495: Financial Services and General Government Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 8595: National Security, Department of State, and Related Programs Appropriations Act, 2027; related to provisions to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products HR 9170: Transportation Housing and Urban Development and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products HR 6938: FY2026 Consolidated Commerce Justice Science, Energy & Water, Interior Appropriations Act; provisions related to contraband vapor products and the Organized Crime Drug Enforcement Task Force S 2256: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2027; potential provisions related to tobacco and nicotine products Tobacco: HR 1798/ S 819: End Tobacco Loopholes Act; all provisions of the bill HR 3838: Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; provisions relating to enforcement efforts regarding illicit e-cigarettes and other unauthorized tobacco products Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction and pathways to authorization for tobacco and nicotine products Discussions concerning proposals to ban characterizing flavors in tobacco products Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products Discussions concerning nicotine analogue products and FDAs regulatory authority over such products Discussions regarding federal excise taxes and the taxation of tobacco products HR 6845: S.T.O.P. Illicit Vapes Act; all provisions of the bill S 3213: Destruction of Hazardous Imports Act; all provisions of the bill S 4303: ENDS Chinese Vapes Act of 2026; all provisions of the bill Discussions related to FDA Guidance on Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization

Government entities reported: HOUSE OF REPRESENTATIVES SENATE Executive Office of the President (EOP) Health & Human Services, Dept of (HHS)

Reported filing-period amount: $3,200,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

THE MENDED HEARTS, INC.

Registrant: TROUTMAN STRATEGIES

2nd Quarter (Apr 1 - June 30)
Jul 16, 2026

Reported lobbying issue

Health Issues: Tracking federal policy relating to heart health, related diseases, treatments, research and development and access to care; Legislation includes the Safe Step Act; issues related to the modernization of the Organ Procurement and Transplantation Network (OPTN), Medicare coverage of anti-obesity medications (AOMs), pharmacy benefit manager (PBM) reform, Medicares drug price negotiation program; Maintaining Investments in New Innovation (MINI) Act (H.R. 1672); Womens Heart Health Expansion Act of 2026 (H.R. 7417/S; 3944); and Cardiovascular Disease Early Detection and Prevention Act (H.R. 8260).

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗

ADVANCED CARE AT HOME (ACH) COALITION

Registrant: SPLITOAK STRATEGIES LLC

1st Quarter (Jan 1 - Mar 31)
Apr 21, 2025

Reported lobbying issue

Medicare/Medicaid: Extension of Acute Hospital Care at Home waiver program; Hospital Inpatient Services Modernization Act (H.R.8260/S.4350 from 118th Congress); H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025

Government entities reported: HOUSE OF REPRESENTATIVES SENATE

Reported filing-period amount: $60,000

This is the amount reported for the filing/reporting period and should not be interpreted as money spent lobbying this bill alone.

View official LDA filing ↗
Discussion notificationsSign in to subscribe
?
No comments yet. Start the conversation.